HONG KONG, Shanghai and FLORHAM PARK, N.J., Nov. 07, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (HUTCHMED) (Nasdaq/AIM:HCM; HKEX:13) today announces that new analyses and updates on the ongoing studies of HMPL-523 and HMPL-306 will be presented at…
HUTCHMED Highlights HMPL-523 Clinical Data to be Presented at the 2021 ASH Annual Meeting
Share this article
More News

Stock Market News and Research Tools
November 3, 2026

Brazil, Thailand, India clarify crypto’s place in law, finance
November 3, 2026

how margin and liquidation work
November 3, 2026
Why Is the Stock Falling?
November 3, 2026

US Stock Market Fails To Recover as $700 Billion Comeback Collapses
November 3, 2026